Santarus, Inc. (Nasdaq:SNTS)
Shares of SNTS soared after the company and Salix Pharmaceuticals, Ltd. reported that they have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of SNTS for $32.00 per share in cash (without interest).
The all-cash transaction values SNTS at approximately $2.6 billion.
SNTS also reported its financial results for the third quarter 2013, posting total revenues of $98.8 million, an 81% increase year over year, and net income of $30.3 million, or $0.38 diluted earnings per share, compared to $9.0 million, or $0.13 diluted earnings per share, in the same period the prior year.
SNTS is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
Air Methods Corporation (Nasdaq:AIRM)
The price on AIRM stock surged after the company reported its financial results, reflecting a return to growth in earnings fueled by strong growth in net revenue per patient transport and more moderate maintenance expenditures as anticipated. AIRM also was upgraded from Buy to Strong Buy with a price target of $55 by brokerage firm Feltl & Co.
For the third quarter 2013, AIRM posted revenue of $252.4 million, a 14% increase year over year, and net income of $35.6 million, or $0.91 per diluted share, compared to $27.8 million, or $0.71 per diluted share, in the same period the prior year.
AIRM is the global leader in air medical transportation. The Air Medical Services Division is the largest provider of air medical transport services in the United States. The United Rotorcraft Division specializes in the design and manufacture of aeromedical and aerospace technology. The Tourism Division is comprised of Sundance Helicopters, Inc., which provides helicopter tours and charter flights, primarily focusing on Grand Canyon tours.
AIRM's fleet of owned, leased or maintained aircraft features over 400 helicopters and fixed wing aircraft.
Read Full Disclaimer at www.drstockpick.com/disclaimer
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.